Skip to main content
Signal8

Protagenic Therapeutics, Inc.\new (PTIX)

Protagenic Therapeutics, Inc. operates as a pharmaceutical company specializing in the development of medicines manufactured from cannabinoid and cannabinoid-like molecules. Protagenic Therapeutics, Inc. was founded in 2004 and is based in Santa Barbara, California.

Sector: Pharmaceutical Preparations

Industry: Biotechnology

Protagenic Therapeutics, Inc. logo

Protagenic Therapeutics, Inc.

OTC:PTIXHealthcare
AH+0.00%$0.4575
Close$0.4575+1.67%
Mkt Cap$828K
EV-
Float1.7M
O/S1.81M
VOL1K sh
$ Vol$485
RVOL0.57×
Inst Own3.7%
SI0.8%
Net Cash/Sh-
EarningsNov 17 · Today
Dilution
Protagenic Therapeutics, Inc. logoOTC:PTIXAH$0.4575+0.00%

Protagenic Therapeutics, Inc.\new (PTIX) dilution facts from SEC filings

Snapshot as of Sep 30, 2026, built from 23 SEC filings.

Shelf registration
S-3 filed Jun 14, 2024, effective Jan 8, 2025
Source: 10-K filed Aug 14, 2026
At-the-market (ATM) program
Yes, sales agreement dated Jul 2, 2021
Source: 10-Q filed Nov 6, 2026
Warrants outstanding
2 warrant series recorded as outstanding
Most recent offering
Not measured

Check another stock for dilution

Facts as recorded in the company's SEC filings. The full snapshot, with instrument terms, share counts and history, is part of Signal8 Pro.

Unlock with Signal8 Pro